Friday, December 1st, 2023
This study evaluated the prevalence of COPD in two cohorts of patients with a smoking history of ≥10 pack‑years who had been hospitalized for acute myocardial infarction. A preliminary diagnosis of clinically significant COPD (defined as an FEV1/FEV6 ratio <0.7 with an FEV1 of <80%) was made using the Vitalograph COPD-6 device.
Vitalograph is a global leader in respiratory diagnostics. We produce high quality, accurate and reliable, respiratory medical devices & services for primary, secondary healthcare and occupational health. We deliver successful clinical trials for leading pharmaceutical companies, biotechs and research organisations.
© Vitalograph 2023 | Privacy Policy | Cookies
Products may not be available in your region. Contact us for more details. Always read the product IFU before use.
